E-mail us: Benjamin's Boardroom wants to hear from you. Email your questions and suggestions to CNN Financial Editor Todd Benjamin. LONDON, England (CNN) -- CNN Financial Editor Todd Benjamin speaks ...

Miroslav Humer, vice president and chief information officer at Case Western Reserve University, was recently named one of the top 10 education CIOs by Classroom Solutions. The honor recognizes ...

Provost Ben Vinson III announced today that Miro Humer has been named the university’s vice president for [U]Tech and chief information officer. “Since he joined Case Western Reserve, Miro has ...

NEW YORK--(BUSINESS WIRE)--Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced ...

BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, ...

EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Swimming New Zealand announced on Monday that coach Lars Humer will “step back” from international coaching, with star pupil Erika Fairweather relocating to Auckland as a result. With the change, ...

A funeral service for Mirko Humer, 74, of Eastlake, a retired auto mechanic, will be 10 a.m. Friday at St. Paul Croatian Catholic Church, 1385 East 40th St., (near St. Clair Ave.) Cleveland. Mr. Humer ...

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) announced Monday the appointment of Kristian Humer as chief financial officer and principal financial officer, according to a statement filed with the U.S ...

Roche Holding AG is a Swiss firm with a drug suddenly selling like hotcakes. Tamiflu is one of the world's only drugs that has proven effective against bird flu. CEO Franz Humer talks about his ...

(RTTNews) - 4D Molecular Therapeutics, Inc. (FDMT), a biotechnology company, Monday announced that it has appointed Kristian Humer as its new chief financial officer. Humer will be replacing Uneek ...